公司新闻/正文
1784 人阅读发布时间:2017-09-11 11:24
| 时间 | 主题 | 演讲嘉宾 |
| 周三, 10月18日 | ||
| 注册、签到 | ||
| 周四, 10月19日 | ||
| 9:00-9:15 | 开场致辞 Opening Speech |
Steve Vermant |
| 9:15-10:00 | IVD诊断试剂开发从理念到临床 - 默克伴您行 Accelerate your IVD commercialization with Merck - Concept to Clinic partnership support |
Caspar Robinson |
| 10:00:10:45 | 定量侧向层析检测的影响因素及工艺优化 The Effects of Optimization on a Quantitative Lateral Flow Test Strip for Human Chorionic Gonadotropin |
Michael Mansfield |
| 10:45-11:15 | Coffee Break | |
| 11:15-12:00 | 四步法开发高效可放大的磁分离工艺 The 4-basic steps to develop an efficient and scalable magnetic separation process |
Lluis Martinez, |
| 12:00-13:30 | Lunch Break | All |
| 13:30-14:15 | 化学发光检测平台研发成功的技术秘笈 Guidance for Successful Chemiluminescent Immunoassay Development |
Annabel Lermo |
| 14:15-15:00 | 免疫比浊检测试剂研发的通用指南 General Guidelines for the development of a Latex-enhanced Turbidimetry reagent |
Sergi Gasso |
| 15:00-15:30 | Coffee Break | |
| 15:30-16:15 | 如何确保LC/MS技术在临床分析中获得高质量的检测结果 Ensuring High Quality in LC/MS for Clinical Analysis |
Frank Michel |
| 16:15-17:00 | 水质,现代化IVD检测技术开发的先行保障 Optimizing modern IVD techniques with high purity water |
Anastasia Domanov |
| 17:00-17:30 | Q&A | |
| 周五, 10月20日 | ||
| 时间 | 主题 | 演讲嘉宾 |
| 9:15-10:00 | 心肌病理诊断中的新型标志物 Emerging markers for the diagnosis of cardiac pathologies |
Mark Mccurley |
| 10:00-10:45 | 蛋白生物标志物检测技术新进展-Luminex, SMC, and Gyros Protein biomarker detection with new technologies -- Luminex, SMC, and Gyros | Xiao Qiang |
| 10:45-11:15 | Coffee Break | |
| 11:15-12:00 | 病理检测技术及新近展 Experts in histology and tissue Diagnostic |
Su Qin |
| 12:00-13:30 | Lunch Break | |
| 13:30-14:15 | 稳定同位素与超极化13C磁共振-肿瘤成像技术的未来Stable Isotopes and Hyperpolarized 13C Magnetic Resonance- The future of imaging in oncology | C. T. Tan |
| 14:15-15:00 | 默克IVD定制服务经验分享 Lessons Learned from Merck IVD Contract Manufacturing Projects |
|
| 15:00-15:30 | Coffee Break | |
| 15:30-16:15 | 产品研发过程潜在风险全规避的探讨 Risk mitigation from concept to clinic |
Jessica Copeland |
| 16:15-17:00 | 国内外体外诊断行业法规的现状与未来发展趋势分析 The present situation and future direction of IVD regulatory in Europe, America, China and Korea |
Jessica Zheng |
| 17:00-17:30 | Q&A | |